Handok Accelerator Company 'Innocube' Completes Startup Planner Registration

Led by CEO Kwon Sohyun, who was in charge of Handok BD

Exterior view of 'Handok Future Complex' in Magok, Gangseo-gu, Seoul, where InnoCube is located (Photo by Handok)

[Asia Economy Reporter Chunhee Lee] InnoCube, a biohealthcare accelerator company, announced on the 28th that it completed registration as a startup accelerator designated by the Ministry of SMEs and Startups on the 16th. InnoCube is an accelerator company established by Handok in September last year. Currently, Handok holds 72.97% of the shares.

InnoCube is an accelerator company that discovers startups specialized in biohealthcare and nurtures creative ideas and technologies to be commercialized. It plans to discover startups with excellent capabilities in various biohealthcare fields such as pharmaceuticals, medical devices, and digital healthcare, provide initial funding, and offer total services including shared research spaces, research equipment infrastructure, project development consulting, and management support.

InnoCube is led by CEO Sohyun Kwon, who was in charge of business development (BD) tasks such as C&BD Executive Director at Handok for over 10 years. Along with her, a team of experts with strategic investment experience and pharmaceutical development experience in the healthcare field provides customized consulting at each stage. Additionally, through active investment and support such as forming venture investment funds, they plan to increase the likelihood of startup business success.

InnoCube discovers investment companies through various methods such as startup contests and networks, and selects final investment companies through multifaceted evaluations by external advisory groups and investment committees. Selected startups undergo a three-year technology verification (PoC, Proof of Concept). For startups that complete verification, follow-up funding and partnerships, as well as additional investments, will be actively considered.

InnoCube is located in Handok Future Complex in Magok, Gangseo-gu, Seoul, which was completed in May. It has office and research spaces that can accommodate up to 10 startups. It also provides shared spaces such as meeting rooms, a cafeteria, a fitness center, and a cafeteria. Currently, MitoTherapeutics, a company developing mitochondria-based anticancer and anti-metabolic disease treatments, and BNJ Biopharma, a company developing new drugs using AI, are tenants.

CEO Sohyun Kwon said, “As the competitiveness of innovative technologies and ideas of domestic biohealthcare startups increases, the need for biohealthcare specialized accelerators suited to domestic conditions is growing. We will provide the best infrastructure and know-how for the success of biohealthcare startups and build a healthier bio venture ecosystem to contribute to the domestic healthcare industry.”